The University of North Carolina at Chapel Hill (UNC-CH) received a $1 Project Grant award from the National Institutes of Health Fogarty International Center (CFDA 93.989 - International Research and Research Training) on September 1, 2024 to conduct the "KUPAMBANA: A Combined Microeconomic Strengthening and Stigma Reduction Intervention for Young People with HIV in Zambia" project. The project aims to address the intersectional challenges of HIV and poverty stigma among young...
This federal Project Grant award, valued at $705,263, was provided by the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) program. The funding supports a 3-year research project at Northwestern University to conduct single-cell tracking of the transformation of lung adenocarcinoma to small cell lung cancer. The project aims to generate novel scientific insights and develop innovative approaches to understanding and managing this complex...
The National Institute of Allergy and Infectious Diseases (NIAID), through the Allergy and Infectious Diseases Research (CFDA 93.855) program, has awarded a $112,943 project grant to the Jos University Teaching Hospital (JUTH) in Nigeria. The grant, effective August 2024 through January 2026, aims to build research administration capabilities and develop electronic grant management systems at JUTH and its partner institutions in West Africa. Specifically, the project will train new and junior...
This federal Project Grant award from the National Cancer Institute's Cancer Research Manpower program (CFDA 93.398) provides $275,837 to Northwestern University over a 5-year period from August 1, 2024 to July 31, 2029. The project aims to investigate the use of a photothermal therapy (PTT) platform with a toll-like receptor 9 agonist, CpGs, as a new therapy for relapsed/refractory B-cell lymphomas. The key objectives are to: 1) characterize the anti-lymphoma immune mechanisms of the PTT/CpG...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $2,332,704 to Northwestern University to conduct innovative observational research across 5 U.S. cities. The project aims to better understand how social contexts and structural inequities drive disparities in HIV and substance use among racial, ethnic, and sexual/gender minority populations, particularly Black men who have sex with men and Black...
The federal Project Grant award, titled "NUCATS CTSA K12 PROGRAM AT NORTHWESTERN UNIVERSITY", is funded by the National Center for Advancing Translational Sciences (NCATS), CFDA 93.350. The $1,078,410 award, effective September 1, 2024 through July 31, 2029, supports the establishment of a K12 program at Northwestern University's Clinical and Translational Sciences Institute (NUCATS). This program aims to train and develop diverse clinical and translational scientists to be resilient...
This federal Project Grant award, provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), aims to implement an innovative HIV self-testing and long-acting injectable HIV treatment and prevention intervention for commercial minibus drivers in Nigeria. The $809,692 award to The George Washington University, with sub-awards to Wake Forest University Health Sciences, University of Rochester, Emory...
This $640,000 federal Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) supports research by Northwestern University to enhance bispecific antibody therapy with nanoparticle-based photothermal therapy. The project aims to develop innovative approaches to transform healthcare for military service members and the broader public. The research will be conducted at Northwestern University's Sponsored...
This $582,959 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) aims to integrate a "Universal Test-and-Connect" (UTC) strategy for HIV prevention and treatment services into two high-volume emergency department (ED) settings in Cape Town, South Africa. The 3-year project, running from September 2024 to September 2027, has three key objectives: Integrate HIV assessment into...
This $598,940 federal Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR) under the Oral Diseases and Disorders Research program (CFDA 93.121) aims to characterize the longitudinal events of oral high-risk human papillomavirus (OHR-HPV) infection among an at-risk population of non-heterosexual males living with or without HIV in Nigeria. The primary objectives are to: 1) determine the association between HIV clinical markers, oral-anogenital contact, and...